Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of PBK-1801 in Healthy Korean Women
NCT04418388Phase 1Completed
- Sponsor
- Pharmbio Korea Inc.
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial of PBK 1801 (3 arms), sponsored by Pharmbio Korea Inc. Primary endpoints: Maximum Plasma Concentration at 5 days, Area Under the Curve to the Last Measurable Concentration at 5 days and 5 more. Started Oct 2019; status: completed.
02
Drugs
PBK 1801
Beyond the preview
Go deeper on NCT04418388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04418388.